A Phase II Clinical Study of LCB01-0371 to Evaluate the EBA, Safety and PK

Clinical trial NCT02836483 · COMPLETED

Trial details

NCT number: NCT02836483
Sponsor: LigaChem Biosciences, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Tuberculosis

Start date: 2016-12-10
Primary completion: 2019-07-01
Enrollment: 79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.